All research papers

Successful Long-Term Survival With Various Modalities of Treatments Combining Minimally Invasive Surgery for Intrahepatic and Extrahepatic Recurrence of Hepatocellular Carcinoma: A Case Report.

Prostate Cancer Recurrence Mimicking a Primary Paranasal Sinus Tumor on ¹⁸F-FDG PET/CT During Treatment for Metastases After 10 Years of Remission.

First Systematic Mapping of Non-Target [68Ga]Ga-DOTANOC Uptake Across Anatomical Sites and Etiologies.

Short-Term Efficacy and Acute Toxicity of CyberKnife-Based Stereotactic Body Radiotherapy for Primary Liver Cancer: A Retrospective Cohort Study

Interfractional Monitoring of Spacer Hydrogel Morphology in Patients With Prostate Cancer Receiving SBRT Treatment.

99mTechnetium SPECT-guided functional liver-sparing radiotherapy planning for recurrent hepatocellular carcinoma: a dosimetric comparison.

Dosimetric impact of spatial separation in combined SBRT and mediastinal radiotherapy for peripheral small cell lung cancer.

Preclinical targeted alpha therapy of B7-H3-positive tumors using [²²⁵Ac]Ac-Macropa-PEG₂-enoblituzumab via EDC/NHS-mediated conjugation.

Prognostic impact of regional lymph node metastasis at castration-resistant prostate cancer diagnosis on survival after radium-223 treatment.

Swiss survey and national diagnostic reference levels for PET/CT examinations in adults.

Clinical and economic outcomes of cabazitaxel versus Lu-PSMA in mCRPC: a US perspective.

IDH-genotype-linked kinase rewiring accompanies enhanced therapeutic response to dual-drug ferritin nanocages in high-grade glioma.

Frameless Stereotactic Radiosurgery (SRS) of Brain Arteriovenous Malformation (AVM); A Systematic Review, Meta-Analysis, and a Specific Analysis on Single-Session SRS.

A simple parameter to guide plan optimization for robotic pancreas SBRT.

Minimally Invasive Surgery for Spinal Metastases: Robotics, Navigation, and the Evolution of Precision Spine Oncology.

Theranostic Approach Using Radioiodinated Trimethoprim Targeting E. coli Dihydrofolate Reductase in Engineered Cells.

Parameterizable salivary gland model for small-scale Monte Carlo radiopharmaceutical therapy dosimetry: evaluation of mouse and human model.

Patient Survival and Its Relation to Tumor Absorbed Dose in [¹⁷⁷Lu]Lu-DOTATATE Therapy of Neuroendocrine Tumors.

[¹⁷⁷Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Hematologic Consequences of Radiopharmaceutical Therapy: From Clonal Hematopoiesis to Therapy-Related Myeloid Neoplasms.

Real-World Outcomes of [¹⁷⁷Lu]Lu-PSMA-617 in the French Early-Access Program for Patients with Metastatic Castration-Resistant Prostate Cancer.

A review of radiotherapy linear accelerator quality control techniques.

Assessment of weight-based variations in effective dose for common PET/CT scans in a tertiary hospital.

Two cases of positive ⁶⁸Ga-PSMA-11 PET imaging in stroke.

Analysis of outcome in patients with different primary localisation of neuroendocrine tumors after PRRT. 10 years single institution experience.

Pleomorphic Giant Cell Carcinoma of the Prostate Treated With Lutetium-177 PSMA.

Improved synthetic CT image quality does not guarantee dosimetric agreement in CBCT-based adaptive proton radiotherapy.

Decoupling the dosimetric impact of setup errors and anatomical deformations in image-guided radiotherapy using diagnostic-quality FBCT and glmmLasso regularization.

Reconstructing delivered dose in real time: a beam physics-embedded, language-model-driven approach.

Online adaptive radiotherapy in pelvic and thoracic cancers - comparing toxicities, clinical outcomes and technical parameters between conventional image-guided radiotherapy and online adaptive radiotherapy - the study protocol for the prospective, registry-based cohort study (PRoART).

Arterial Spin Labeling-Derived Fractional Tumor Burden as a Primary Biomarker for Differentiating Recurrent Tumor from Radiation Necrosis After Stereotactic Radiosurgery.

A deep learning framework for radiotherapy dose prediction: from MLC motion to patient-specific dose perturbation.

Analytical convolution/superposition modelling of one-dimensional dose profiles with asymmetric energy deposition kernels in homogeneous media.

Genotype-location interaction defines the SSTR-PET phenotype in paragangliomas and pheochromocytomas.

Tumour-absorbed dose and efficacy of peptide receptor radionuclide therapy with [⁹⁰Y]Y-DOTATOC in patients with refractory meningioma: a single-centre experience.

68Ga prostate-specific membrane antigen PET/computed tomography in benign and malignant prostatic lesions: a study of maximum standardized uptake value and uptake patterns with clinicopathological correlation.

Multimodal Management of Advanced Metastatic Prostate Cancer: Excellent Response Following Resection of Brain Metastasis and 177Lu-PSMA Therapy.

Early Follicular Lymphoma Grading via PET-CT Fusion and Bayesian Deep Learning.

Performance evaluation of the Biograph Trinion EP2 PET/CT system according to NEMA NU2-2018.

A New Fluorine-18-Fluoroethyltyrosine Positron-Emission-Tomography/Magnetic-Resonance-Based Tumor Resection Plan Improved the Prognosis of Glioblastoma Patients. A Multicenter Validated Study.

Evolutionary landscape and collaborative networks of global theranostic research in nuclear medicine: a visual bibliometric analysis.

Association of prostate-specific antigen kinetics with gallium-68 prostate-specific membrane antigen PET/computed tomography positivity in biochemical recurrence after radical prostatectomy.

Efficacy of intra-arterial [ 177 Lu]Lu-DOTATATE vs. continuation intravenous [ 177 Lu]Lu-DOTATATE peptide receptor radionuclide therapy in nonresponding locally advanced inoperable or liver-dominant metastatic gastroenteropancreatic neuroendocrine tumors.

Preparing for Practice, Part 2: A Simulation-Based Curriculum Framework for Radiopharmaceutical Therapy Education-A Program Improvement Initiative.

Stable core-encapsulation of indium-111 in crosslinked polyionic complex micelles and assessment of its biodistribution.

Quantifying daily residual motion of bilateral diaphragmatic domes using an iterative detection algorithm for breath-hold radiation therapy.

Brain metastases in triple-negative breast cancer: a systematic review of current trends, treatment strategies, and outcomes.

The risk of sinus vein thrombosis in patients treated with intraoperative radiotherapy for sinus adjacent tumours.

Pancreas SBRT requires online adaptive treatment to adequately manage motion.

Radiation Safety Knowledge, Perceptions, and Self-Reported Practices Among Healthcare Workers in Radiology and Nuclear Medicine: A Cross-Sectional Survey.

Workflow and dosimetric results for direct-to-unit single-fraction adaptive lung SBRT delivered on the ONE-STOP prospective pilot clinical trial.

Clinical utility of early MRI follow-up after radiosurgery for solitary meningiomas: A single center, retrospective analysis.

Macropa-Based 225Ac-Labeled RGD Peptides for Targeted Alpha Therapy.

Radiotherapy strategies for prostate cancer: Techniques, outcomes, and patient care.

Real-world treatment of oligometastatic hormone-sensitive prostate cancer: impact of androgen receptor pathway inhibitors, metastasis-directed therapy and primary tumor radiotherapy on survival.

Dosimetry Results from the Phase 1b/3 ACTION-1 Trial of [²²⁵Ac]Ac-DOTATATE (RYZ101) in Patients with Somatostatin Receptor-Expressing, Well-Differentiated GEP-NETs.

Diagnostic Value of Routine Delayed Pelvic Imaging for Patients with Biochemical Recurrence of Prostate Cancer Undergoing ⁶⁸Ga-PSMA PET/CT.

Nephron-Level Dosimetry Reveals Increased Absorbed Dose Heterogeneity of ¹⁶¹Tb- Versus ¹⁷⁷Lu-DOTATATE in Murine Kidneys Despite Similar Pharmacokinetics.

Thrombotic Microangiopathy in Patients Treated with ¹⁷⁷Lu-PSMA Combination Therapies.

Evaluation of skin dose robustness in breast radiotherapy using VMAT planning technique: a phantom-based surface dosimetry study.